HPV vaccine knowledge among patients and healthcare providers
Part of Infections clinical trials.
This study asks people (ages 9–79) and healthcare providers at Assiut University Hospital about what they know and think about the HPV vaccine. The goal is to understand why some people choose not to get vaccinated and how to encourage vaccination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 9 and 79 years old.
- You are either a patient or relative visiting the Obstetrics/Gynecology or Family Medicine clinics at Assiut University Hospital, or a healthcare provider in those departments.
- You have not yet received the full HPV vaccine series.
- You do not have a severe memory or thinking problem, serious mental illness, or you are not currently in the hospital or very sick.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps researchers understand why some teenage girls and their families choose or don't choose HPV vaccination, and tests a new way to support families in making this decision together. The HPV vaccine helps prevent certain cancers later in life.
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
This study tests whether a special education program based on the transtheoretical model improves nursing students' knowledge about HPV, their health beliefs, and their intentions to get vaccinated. It aims to help students make informed decisions about HPV prevention.
This study tests whether teaching mothers about HPV (a virus that can cause certain cancers) helps them get their child vaccinated. If you join, you'll learn about HPV and the vaccine during a short education session.
This study tests whether a special education program and one-on-one motivational talks can help women learn more about HPV and decide about the vaccine. If you join, you will attend three sessions that explain HPV in simple terms and support your choices.
This study tests if a single dose of the HPV vaccine (Gardasil 9) can lower the amount of HPV virus in women who already have the virus, potentially reducing how easily it spreads. It will help us learn if vaccination can protect partners and communities.
Hear when a new Human Papilloma Virus (HPV) Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.